Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-14 Purchase | 2021-05-18 4:45 pm | Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick CEO | 13,000 | $9.4561 | $122,929 | 13,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-03 Option Award | 2022-01-05 4:08 pm | N/A N/A | Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick CEO | 123,600 | $0 | 123,600 (Direct) | View |
| 2021-02-05 Option Award | 2021-04-07 4:03 pm | N/A 2031-02-04 | Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick CEO | 1,124,832 | $0 | 1,124,832 (Direct) | View |
| 2021-02-05 Ownership | 2021-02-10 5:33 pm | N/A 2029-11-11 | Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick CEO | 0 | $0 | 972,976 (Direct) | View |
| 2018-02-13 Disposition | 2018-02-13 4:41 pm | N/A N/A | Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer | 30,228 | $18 | 0 (Direct) | View |
| 2018-02-13 Disposition | 2018-02-13 4:41 pm | N/A 2027-04-03 | Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer | 150,000 | $7.35 | 0 (Direct) | View |